Overall rank by patents
#27,028
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 14 technology areas, active 2017–2021. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;).
The verdict
Orthobond holds 10 US patents across 14 technology areas, rank #27,028 of 50,000 tracked assignees.
Orthobond Corporation has been granted 10 US utility patents between 2017 and 2021, placing Orthobond Corporation at rank #27,028 across all assignees tracked by PlainPatent. This portfolio spans 14 distinct Cooperative Patent Classification (CPC) subclasses, averaging 23.7 claims per patent with primary concentration in A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;). As a US Corporation, Orthobond Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Orthobond sits between Orbite Technologies Inc. (10 patents, rank #27,024) and OSI Optoelectronics, Inc. (10 patents, rank #27,032) - the closest US assignees by grant volume. The composite Innovation Score of 35.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 7 in the 2015–2019 window, a -57% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Orthobond Corporation's 23.7 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 14 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Orthobond Corporation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ORBITE TECHNOLOGIES INC.
10 patents
ORELL FUSSLI SICHERHEITSDRUCK AG
10 patents
ORICA EXPLOSIVES TECHNOLOGY PTY LTD
10 patents
ORIENTAL SYSTEM TECHNOLOGY INC.
10 patents
ORTHODONTIC RESEARCH AND DEVELOPMENT, S.L.
10 patents
ORTHOFIX INC.
10 patents
OSAKA TITANIUM TECHNOLOGIES CO., LTD.
10 patents
OSI Optoelectronics, Inc.
10 patents
ORTHOBOND CORPORATION
10 patents
What this shows Orthobond holds 10 patents at rank #27,028, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #27,028 in granted patent volume.
Other assignees with the most granted patents in Orthobond's primary technology class.
Orthobond's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
36 Top 48% higher than 52% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 10.0% |
| 2018 | 3 | 30.0% |
| 2019 | 3 | 30.0% |
| 2020 | 2 | 20.0% |
| 2021 | 1 | 10.0% |
Top 14 of 14 technology areas
Overall rank by patents
#27,028
Across all tracked assignees
35.7 out of 100
How to use this portfolio
Orthobond's 10 grants land it in the top 48% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.